Inappropriate interventions during the long-term follow-up of patients with an implantable defibrillator

Thomas Stuber1, Christa Eigenmann, Etienne Delacrétaz

  • 1Swiss Cardiovascular Center Bern, University of Bern, Bern, Switzerland.

Insights

Inappropriate implantable cardioverter-defibrillator (ICD) interventions affect patient quality of life. Supraventricular arrhythmias and prior ventricular tachycardia increase the risk of these events, necessitating targeted interventions.

Area of Science:

  • Cardiology
  • Electrophysiology
  • Medical Device Technology

Background:

  • Inappropriate implantable cardioverter-defibrillator (ICD) interventions negatively impact patient quality of life, increase hospitalizations, and reduce cost-effectiveness.
  • Identifying the incidence, causes, and at-risk patient populations for inappropriate ICD interventions is crucial for optimizing patient care.

Purpose of the Study:

  • To determine the incidence and causes of inappropriate ICD interventions.
  • To identify patient-specific risk factors associated with inappropriate ICD interventions.

Main Methods:

  • An observational, longitudinal study involving consecutive patients undergoing ICD implantation.
  • Systematic review and analysis of stored electrograms from episodes triggering ICD interventions.
  • Classification of inappropriate ICD interventions by cause and identification of risk factors.

Main Results:

  • A total of 214 patients were followed for a median of 2.7 years.
  • Inappropriate ICD interventions occurred in 27% of patients (58/214), with supraventricular arrhythmias (atrial fibrillation/flutter, sinus tachycardia) being the most common causes.
  • Sustained ventricular tachycardia as the index arrhythmia was the only identified risk factor for inappropriate ICD interventions.

Conclusions:

  • A significant proportion of ICD patients experience inappropriate interventions, primarily triggered by supraventricular arrhythmias.
  • Patients with a history of ventricular tachycardia are at increased risk for inappropriate ICD interventions.
  • Consideration of specific interventions to mitigate the risk of inappropriate ICD interventions in high-risk patients is recommended.
Abstract

Related Concept Videos

Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
Heart Failure VI: Adjunct Therapies01:22

Heart Failure VI: Adjunct Therapies

Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
Cardiac Catheterization IV: Nursing Management01:26

Cardiac Catheterization IV: Nursing Management

Nursing responsibilities before cardiac catheterization include:Assess for allergies and establish baseline health status.Before cardiac catheterization, assess the patient for allergies to contrast dye. Perform a comprehensive baseline assessment, including vital signs, heart and breath sounds, and a neurovascular assessment of the extremities, noting distal pulses, skin color, and temperature. Instruct the patient to fast for 8-12 hours before the procedure. Evaluate baseline laboratory...
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
Cardiopulmonary Resuscitation III: AED Use01:23

Cardiopulmonary Resuscitation III: AED Use

Introduction to AEDAn Automated External Defibrillator (AED) is a portable medical device that analyzes the heart's rhythm and, if necessary, delivers an electrical shock to help the heart re-establish an effective rhythm during sudden cardiac arrest (SCA). SCA occurs when the heart suddenly and unexpectedly stops beating, leading to a loss of blood flow to the brain and other vital organs. In such emergencies, time is of the essence, and using an AED, combined with Cardiopulmonary...
Dysrhythmias VI: Management of Dysrhythmias01:25

Dysrhythmias VI: Management of Dysrhythmias

Dysrhythmia management involves a multifaceted approach, incorporating pharmacological treatments, medical procedures, surgical interventions, lifestyle modifications, and patient education.Pharmacological ManagementAntiarrhythmic Drugs:Class I (Sodium Channel Blockers): This class includes quinidine and procainamide, which reduce the speed of impulse conduction in the heart, stabilize the cardiac membrane, and control arrhythmias. Quinidine and procainamide are Class IA agents that prolong the...